Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429

Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology

Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028

Knocking down barriers: advances in siRNA delivery

Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115

Rational design of cationic lipids for siRNA delivery

Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822 · cited 1×

Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures 1

Abdel‐Magid, A. F., Carson, K. G., Harris, B. D., Maryanoff, C. A., & Shah, R. D. (1996) · The Journal of Organic Chemistry · doi:10.1021/jo960057x · Cited by 1,521

Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms

Akinc, A., Querbes, W., De, S., Qin, J., Frank-Kamenetsky, M., Jayaprakash, K. N., Jayaraman, M., Rajeev, K. G., Cantley, W. L., Dorkin, J. R., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.85 · Cited by 1,261

Bio-inspired, bioengineered and biomimetic drug delivery carriers

Yoo, J., Irvine, D. J., Discher, D. E., & Mitragotri, S. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3499 · Cited by 1,251

The promises and pitfalls of RNA-interference-based therapeutics

Castanotto, D., & Rossi, J. J. (2009) · Nature · doi:10.1038/nature07758 · Cited by 1,241

A combinatorial library of lipid-like materials for delivery of RNAi therapeutics

Akinc, A., Zumbuehl, A., Goldberg, M., Leshchiner, E. S., Busini, V., Hossain, N., Bacallado, S. A., Nguyen, D. N., Fuller, J., Alvarez, R., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1402 · Cited by 1,150

Genetic Heterogeneity in Human Disease

McClellan, J., & King, M.-C. (2010) · Cell · doi:10.1016/j.cell.2010.03.032 · Cited by 981

Personalizing Biomaterials for Precision Nanomedicine Considering the Local Tissue Microenvironment

Oliva, N., Unterman, S. A., Zhang, Y., Conde, J., Song, H. S., & Artzi, N. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201400778 · Cited by 55

CD47 peptide-cloaked lipid nanoparticles promote cell-specific mRNA delivery

Papp, T. E., Zeng, J., Shahnawaz, H., Akyianu, A., Breda, L., Yadegari, A., Steward, J., Shi, R., Li, Q., Mui, B. L., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.03.018 · Cited by 59

Molecular Tuning of a Vitamin E-Scaffold pH-Sensitive and Reductive Cleavable Lipid-like Material for Accelerated in Vivo Hepatic siRNA Delivery

Akita, H., Noguchi, Y., Hatakeyama, H., Sato, Y., Tange, K., Nakai, Y., & Harashima, H. (2015) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5b00203 · Cited by 53

Cell Subtypes Within the Liver Microenvironment Differentially Interact with Lipid Nanoparticles

Sago, C. D., Krupczak, B. R., Lokugamage, M. P., Gan, Z., & Dahlman, J. E. (2019) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-019-00573-4 · Cited by 53

The nanomedicine rush: New strategies for unmet medical needs based on innovative nano DDS

Sato, Y., Nakamura, T., Yamada, Y., & Harashima, H. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.12.032 · Cited by 50

Ionizable liposomal siRNA therapeutics enables potent and persistent treatment of Hepatitis B

Huang, Y., Zheng, S., Guo, Z., du Jeu, X. D. M., Liang, X., Yang, Z., Zhang, H., Gao, S., & Liang, Z. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00859-y · Cited by 48

Next generation self-replicating RNA vectors for vaccines and immunotherapies

Aliahmad, P., Miyake-Stoner, S. J., Geall, A. J., & Wang, N. S. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00435-8 · Cited by 50

RGD peptide-based lipids for targeted mRNA delivery and gene editing applications

Qin, J., Xue, L., Gong, N., Zhang, H., Shepherd, S. J., Haley, R. M., Swingle, K. L., & Mitchell, M. J. (2022) · RSC Advances · doi:10.1039/d2ra02771b · Cited by 54

PEG-lipid micelles enable cholesterol efflux in Niemann-Pick Type C1 disease-based lysosomal storage disorder

Brown, A., Patel, S., Ward, C., Lorenz, A. S., Ortiz, M., DuRoss, A. N., Wieghardt, F., Esch, A. M., Otten, E. G., Heiser, L. M., et al. (2016) · Scientific Reports · doi:10.1038/srep31750 · Cited by 47

pH-labile PEGylation of siRNA-loaded lipid nanoparticle improves active targeting and gene silencing activity in hepatocytes

Hashiba, K., Sato, Y., & Harashima, H. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.07.046 · Cited by 49

Cellular Trafficking of Nanotechnology‐Mediated mRNA Delivery

Huang, P., Deng, H., Wang, C., Zhou, Y., & Chen, X. S. (2023) · Advanced Materials · doi:10.1002/adma.202307822 · Cited by 53

Electrostatic adsorption of polyanions onto lipid nanoparticles controls uptake, trafficking, and transfection of RNA and DNA therapies

Nabar, N., Dacoba, T. G., Covarrubias, G., Romero-Cruz, D., & Hammond, P. T. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2307809121 · Cited by 54

Advances in the design and delivery of RNA vaccines for infectious diseases

Lokras, A. G., Bobak, T. R., Baghel, S. S., Sebastiani, F., & Foged, C. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115419 · Cited by 52

Fluorocarbon Modified Low-Molecular-Weight Polyethylenimine for siRNA Delivery

Johnson, M. E., Shon, D. J., Guan, B. M., Patterson, J. P., Oldenhuis, N. J., Eldredge, A. C., Gianneschi, N. C., & Guan, Z. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00216 · Cited by 49

Lipid Nanoparticle-Associated Inflammation is Triggered by Sensing of Endosomal Damage: Engineering Endosomal Escape Without Side EffectsPreprint

Omo‐Lamai, S., Wang, Y., Patel, M. N., Essien, E., Shen, M., Majumdar, A., Espy, C. L., Wu, J., Channer, B., Tobin, M. P., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.16.589801 · Cited by 48

Advances in the application of nanotechnology in reducing cardiotoxicity induced by cancer chemotherapy

Su, X., Zhang, X., Liu, W., Yang, X., An, N., Yang, F., Sun, J., Xing, Y., & Shang, H. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.08.003 · Cited by 47

Hyaluronate siRNA nanoparticles with positive charge display rapid attachment to tumor endothelium and penetration into tumors

Luo, J., Schmaus, J., Cui, M., Hörterer, E., Wilk, U., Höhn, M., Däther, M., Berger, S., Benli‐Hoppe, T., Peng, L., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.10.022 · Cited by 47

Transfection by cationic gemini lipids and surfactants

Damen, M., Groenen, A., van Dongen, S. F. M., Nolte, R. J. M., Scholte, B. J., & Feiters, M. C. (2018) · MedChemComm · doi:10.1039/c8md00249e · Cited by 46

In Situ Characterization of the Protein Corona of Nanoparticles In Vitro and In Vivo

Latreille, P., Rabanel, J., Goas, M. L., Salimi, S., Arlt, J., Patten, S. A., Ramassamy, C., Hildgen, P., Martinez, V. A., & Banquy, X. (2022) · Advanced Materials · doi:10.1002/adma.202203354 · Cited by 45

HDL and microRNA therapeutics in cardiovascular disease

Michell, D. L., & Vickers, K. C. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.09.001 · Cited by 45

Targeted si-RNA with liposomes and exosomes (extracellular vesicles): How to unlock the potential

Antimisiaris, S. G., Mourtas, S., & Παπαδιά, Κ. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.01.056 · Cited by 46

Modifying a Commonly Expressed Endocytic Receptor Retargets Nanoparticles in Vivo

Sago, C. D., Lokugamage, M. P., Lando, G. N., Djeddar, N., Shah, N. N., Syed, C., Bryksin, A. V., & Dahlman, J. E. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b03149 · Cited by 46

Effects of local structural transformation of lipid-like compounds on delivery of messenger RNA

Li, B., Luo, X. L., Deng, B., Giancola, J. B., McComb, D. W., Schmittgen, T. D., & Dong, Y. (2016) · Scientific Reports · doi:10.1038/srep22137 · Cited by 44

Innovative nanotechnologies for enhancing nucleic acids/gene therapy: Controlling intracellular trafficking to targeted biodistribution

Nakamura, T., Yamada, Y., Sato, Y., Khalil, I. A., & Harashima, H. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119329 · Cited by 45

Nanoscale delivery platforms for RNA therapeutics: Challenges and the current state of the art

Rhym, L. H., & Anderson, D. G. (2022) · Med · doi:10.1016/j.medj.2022.02.001 · Cited by 45

Molecular Chameleon Carriers for Nucleic Acid Delivery: The Sweet Spot between Lipoplexes and Polyplexes

Thalmayr, S., Grau, M., Peng, L., Pöhmerer, J., Wilk, U., Folda, P., Yazdi, M., Weidinger, E., Burghardt, T., Höhn, M., et al. (2023) · Advanced Materials · doi:10.1002/adma.202211105 · Cited by 45

Understanding Intracellular Biology to Improve mRNA Delivery by Lipid Nanoparticles

Hunter, M. R., Cui, L., Porebski, B. T., Pereira, S. G. T., Sonzini, S., Odunze, U., Iyer, P., Engkvist, O., Lloyd, R. L., Peel, S. E., et al. (2023) · Small Methods · doi:10.1002/smtd.202201695 · Cited by 44

Engineered mRNA Delivery Systems for Biomedical Applications

Wang, J., Zhu, H., Gan, J., Liang, G., Li, L., & Zhao, Y. (2023) · Advanced Materials · doi:10.1002/adma.202308029 · Cited by 46

Organic Nanocarriers for Delivery and Targeting of Therapeutic Agents for Cancer Treatment

Peng, Y., Bariwal, J. B., Kumar, V., Tan, C., & Mahato, R. I. (2020) · Advanced Therapeutics · doi:10.1002/adtp.201900136 · Cited by 44

Computational and Experimental Approaches to Investigate Lipid Nanoparticles as Drug and Gene Delivery Systems

Chan, C., Du, S., Dong, Y., & Cheng, X. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666201126162945 · Cited by 45

Scope and challenges of nanoparticle-based mRNA delivery in cancer treatment

Karim, M. E., Haque, S. T., Al-Busaidi, H., Bakhtiar, A., Tha, K. K., Holl, M. M. B., & Chowdhury, E. H. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01418-x · Cited by 45

Bioinspired Lipid Nanocarriers for RNA Delivery

Golubovic, A., Tsai, S., & Li, B. (2023) · ACS Bio & Med Chem Au · doi:10.1021/acsbiomedchemau.2c00073 · Cited by 49

The emerging potential of siRNA nanotherapeutics in treatment of arthritis

Kumari, A., Kaur, A., & Aggarwal, G. (2023) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2023.100845 · Cited by 46

Systemic siRNA Nanoparticle-Based Drugs Combined with Radiofrequency Ablation for Cancer Therapy

Ahmed, M., Kumar, G., Navarro, G., Wang, Y., Gourevitch, S., Moussa, M., Rozenblum, N., Levchenko, T. S., Galun, E., Torchilin, V. P., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128910 · Cited by 42

Poly(d,l-lactic acid)-glycerol-based nanoparticles for curcumin delivery

Yoon, I., Park, J.-H., Kang, H. J., Choe, J. H., Goh, M. S., Kim, D., & Cho, H. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.04.046 · Cited by 42

Screening of efficient siRNA carriers in a library of surface-engineered dendrimers

Liu, H., Chang, H., Lv, J., Jiang, C., Li, Z., Wang, F., Wang, H., Wang, M., Liu, C., Wang, X., et al. (2016) · Scientific Reports · doi:10.1038/srep25069 · Cited by 43

Development of Cationic Quaternary Ammonium Sulfonamide Amino Lipids for Nucleic Acid Delivery

Miller, J. B., Kós, P., Tieu, V., Zhou, K., & Siegwart, D. J. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b15982 · Cited by 43

Identification of Novel Fibrosis Modifiers by In Vivo siRNA Silencing

Vollmann, E. H., Cao, L., Amatucci, A., Reynolds, T. L., Hamann, S., Dalkilic-Liddle, I., Cameron, T. O., Hoßbach, M., Kauffman, K. J., Mir, F. F., et al. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.04.014 · Cited by 41

Strategies for improving the safety and RNAi efficacy of noncovalent peptide/siRNA nanocomplexes

Wang, J., Chen, G., Liu, N., Han, X., Zhao, F. H., Zhang, L., & Chen, P. (2022) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2022.102638 · Cited by 42

Nanotechnology for In vivo Targeted siRNA Delivery

Dahlman, J. E., Kauffman, K. J., Langer, R., & Anderson, D. G. (2014) · Advances in genetics · doi:10.1016/b978-0-12-800148-6.00003-1 · Cited by 41

Design of synthetic materials for intracellular delivery of RNAs: From siRNA-mediated gene silencing to CRISPR/Cas gene editing

Miller, J. B., & Siegwart, D. J. (2018) · Nano Research · doi:10.1007/s12274-018-2099-4 · Cited by 41

Synthesis and characterization of manganese ferrite nanoparticles, and its interaction with bovine serum albumin: A spectroscopic and molecular docking approach

Gandhi, S., & Roy, I. (2019) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2019.111871 · Cited by 40

Metabolism of 13C5-hydroxyproline in mouse models of Primary Hyperoxaluria and its inhibition by RNAi therapeutics targeting liver glycolate oxidase and hydroxyproline dehydrogenase

Li, X., Knight, J. L., Fargue, S., Buchalski, B., Guan, Z., Inscho, E. W., Liebow, A., Fitzgerald, K. J., Querbes, W., Lowther, W. T., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.001 · Cited by 39

High-throughput screening of nanoparticles in drug delivery

Tomé, I., Francisco, V., Fernandes, H., & Ferreira, L. (2021) · APL Bioengineering · doi:10.1063/5.0057204 · Cited by 39

Building the design, translation and development principles of polymeric nanomedicines using the case of clinically advanced poly(lactide(glycolide))–poly(ethylene glycol) nanotechnology as a model: An industrial viewpoint

Reddy, L. H., & Bazile, D. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.08.012 · Cited by 39

Rational nanocarrier design towards clinical translation of cancer nanotherapy

Guo, D., Ji, X., & Luo, J. (2021) · Biomedical Materials · doi:10.1088/1748-605x/abe35a · Cited by 39

Biohybrid Nanoparticles to Negotiate with Biological Barriers

Mohammadi, M. R., Corbo, C., Molinaro, R., & Lakey, J. R. T. (2019) · Small · doi:10.1002/smll.201902333 · Cited by 37

Enhancing non-viral DNA delivery systems: Recent advances in improving efficiency and target specificity

Hosseini-Kharat, M., Bremmell, K. E., Grubor‐Bauk, B., & Prestidge, C. A. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.12.002 · Cited by 37

Machine learning techniques for lipid nanoparticle formulation

Li, H., Zhao, Y., & Xu, C. (2025) · Nano Convergence · doi:10.1186/s40580-025-00502-4 · Cited by 40

Development of a multifunctional envelope-type nano device and its application to nanomedicine

Sato, Y., Nakamura, T., Yamada, Y., & Harashima, H. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.042 · Cited by 37

Liver‐targeted gene therapy: Approaches and challenges

Aravalli, R. N., Belcher, J. D., & Steer, C. J. (2015) · Liver Transplantation · doi:10.1002/lt.24122 · Cited by 37

Vector-delivered artificial miRNA effectively inhibited replication of Chikungunya virus

Saha, A., Bhagyawant, S. S., Parida, M., & Dash, P. K. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.08.019 · Cited by 35

From fiction to science: clinical potentials and regulatory considerations of gene editing

Schacker, M., & Seimetz, D. (2019) · Clinical and Translational Medicine · doi:10.1186/s40169-019-0244-7 · Cited by 36

Emerging Classes of Small Non-Coding RNAs With Potential Implications in Diabetes and Associated Metabolic Disorders

Jacovetti, C., Bayazit, M. B., & Regazzi, R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.670719 · Cited by 37

Lipid-peptide nanocomplexes for mRNA delivery in vitro and in vivo

Grant-Serroukh, D., Hunter, M. R., Maeshima, R., Tagalakis, A. D., Aldossary, A. M., Allahham, N., Williams, G. R., Edbrooke, M. R., Desai, A. S., & Hart, S. L. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.06.018 · Cited by 37

Downregulation of the Arg/N-degron Pathway Sensitizes Cancer Cells to Chemotherapy In Vivo

Leboeuf, D., Abakumova, T. O., Prikazchikova, T. A., Rhym, L. H., Anderson, D. G., Zatsepin, T. S., & Piatkov, K. I. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.01.021 · Cited by 32

Artificial Platelets for Efficient siRNA Delivery to Clear “Bad Cholesterol”

Zhang, Y., Qin, Y., Li, H., Peng, Q., Wang, P., Yang, L., Chen, S., Li, M., Fu, J., Yu, X., et al. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c07559 · Cited by 33

siRNA-nanoparticle conjugate in gene silencing: A future cure to deadly diseases?

Acharya, R., Saha, S., Ray, S., Hazra, S., Mitra, M. K., & Chakraborty, J. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.03.009 · Cited by 33

Emerging prospects of mRNA cancer vaccines: mechanisms, formulations, and challenges in cancer immunotherapy

Laila, U. E., An, W., & Xu, Z.-X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1448489 · Cited by 34

Recommendations of the Oligonucleotide Safety Working Group's Formulated Oligonucleotide Subcommittee for the Safety Assessment of Formulated Oligonucleotide-Based Therapeutics

Marlowe, J. L., Akopian, V., Karmali, P. P., Kornbrust, D. J., Lockridge, J. A., & Semple, S. C. (2017) · Nucleic Acid Therapeutics · doi:10.1089/nat.2017.0671 · Cited by 32

Protein and mRNA Delivery Enabled by Cholesteryl‐Based Biodegradable Lipidoid Nanoparticles

Li, Y., Jarvis, R., Zhu, K., Glass, Z., Ogurlu, R., Gao, P., Li, P., Chen, J., Yu, Y., Yang, Y., et al. (2020) · Angewandte Chemie · doi:10.1002/ange.202004994 · Cited by 32

Intracellular Antibody Delivery Mediated by Lipids, Polymers, and Inorganic Nanomaterials for Therapeutic Applications

Li, Y., Li, P., Li, R., & Xu, Q. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000178 · Cited by 32

Pre-clinical non-viral vectors exploited for in vivo CRISPR/Cas9 gene editing: an overview

Rouatbi, N., McGlynn, T., & Al‐Jamal, K. T. (2022) · Biomaterials Science · doi:10.1039/d1bm01452h · Cited by 33

Peptide-based vectors: recent developments

Cerrato, C. P., Lehto, T., & Langel, Ü. (2014) · BioMolecular Concepts · doi:10.1515/bmc-2014-0024 · Cited by 33

Innovative Technologies in Nanomedicines: From Passive Targeting to Active Targeting/From Controlled Pharmacokinetics to Controlled Intracellular Pharmacokinetics

Sato, Y., Sakurai, Y., Kajimoto, K., Nakamura, T., Yamada, Y., Akita, H., & Harashima, H. (2016) · Macromolecular Bioscience · doi:10.1002/mabi.201600179 · Cited by 32

Synthesis and characterization of silver nanoparticles developed using a novel lipopeptide(s) biosurfactant and evaluating its antimicrobial and cytotoxic efficacy.

Chauhan, V., Dhiman, V. K., Mahajan, G., Pandey, A., & Kanwar, S. S. (2022) · Process Biochemistry · doi:10.1016/j.procbio.2022.11.002 · Cited by 31

Future Nanomedicine for The Diagnosis and Treatment of Osteoarthritis

Eichaker, L. R., Cho, H., Duvall, C. L., Werfel, T. A., & Hasty, K. A. (2014) · Nanomedicine · doi:10.2217/nnm.14.138 · Cited by 31

Modular Design of Lipopeptide‐Based Organ‐Specific Targeting (POST) Lipid Nanoparticles for Highly Efficient RNA Delivery

Tang, C., Zhang, Y., Li, B., Fan, X., Wang, Z., Su, R., Qi, W., & Wang, Y. (2025) · Advanced Materials · doi:10.1002/adma.202415643 · Cited by 31

Overcoming Barriers: Clinical Translation of siRNA Nanomedicines

Tieu, T., Wei, Y., Cifuentes‐Rius, A., & Voelcker, N. H. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100108 · Cited by 31

A Synergistic Lipid Nanoparticle Encapsulating mRNA Shingles Vaccine Induces Potent Immune Responses and Protects Guinea Pigs from Viral Challenges

Cheng, X., Liu, S., Sun, J., Liu, L., Ma, X., Li, J., Fan, B., Chen, Y., Zhao, Y., Liu, S., et al. (2023) · Advanced Materials · doi:10.1002/adma.202310886 · Cited by 30

Liver-Targeting Nanoplatforms for the Induction of Immune Tolerance

Kusumoputro, S., Au, C., Lam, K. H., Park, N., Hyun, A., Kusumoputro, E., Wang, X., & Xia, T. (2023) · Nanomaterials · doi:10.3390/nano14010067 · Cited by 31

Evaluation of the anti-cancer efficacy of lipid nanoparticles containing siRNA against HPV16 E6/E7 combined with cisplatin in a xenograft model of cervical cancer

Kang, S. W., Kang, O.-J., Lee, J., Kim, H.-J., Jung, H., Kim, H., Lee, S., Kim, Y., & Choi, E. K. (2024) · PLoS ONE · doi:10.1371/journal.pone.0298815 · Cited by 29

Enzymatic Synthesis of Self-assembled Dicer Substrate RNA Nanostructures for Programmable Gene Silencing

Jang, B., Kim, B. Y., Kim, H., Kwon, H., Kim, M., Seo, Y., Colas, M., Jeong, H., Jeong, E. H., Lee, K., et al. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b01267 · Cited by 29

Targeting Non-coding RNA for Glioblastoma Therapy: The Challenge of Overcomes the Blood-Brain Barrier

Sharma, R. K., Calderon, C., & Vivas‐Mejía, P. E. (2021) · Frontiers in Medical Technology · doi:10.3389/fmedt.2021.678593 · Cited by 29

In vitro 3D model and miRNA drug delivery to target calcific aortic valve disease

van der Ven, C. F. T., Wu, P.-J., Tibbitt, M. W., van Mil, A., Sluijter, J. P. G., Langer, R., & Aïkawa, E. (2017) · Clinical Science · doi:10.1042/cs20160378 · Cited by 29

Lipid nanoparticles for the inhalation of mRNA

Chang, R. Y. K., & Chan, H. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00794-x · Cited by 29

Synthetic high-density lipoprotein-like nanoparticles for cancer therapy

Foit, L., Giles, F. J., Gordon, L. I., & Thaxton, C. S. (2014) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2015.990889 · Cited by 27

Nucleic acid delivery and nanoparticle design for COVID vaccines

Andresen, J. L., & Fenton, O. S. (2021) · MRS Bulletin · doi:10.1557/s43577-021-00169-2 · Cited by 32

Oligonucleotide-Based Therapies for Chronic HBV Infection: A Primer on Biochemistry, Mechanisms and Antiviral Effects

Vaillant, A. (2022) · Viruses · doi:10.3390/v14092052 · Cited by 30

Harnessing Topology and Stereochemistry of Glycidylamine‐Derived Lipid Nanoparticles for in Vivo mRNA Delivery to Immune Cells in Spleen and Their Application for Cancer Vaccination

Elwakil, M. M. A., Suzuki, R., Khalifa, A. M., Elshami, R. M., Isono, T., Elewa, Y. H. A., Sato, Y., Nakamura, T., Satoh, T., & Harashima, H. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202303795 · Cited by 30

High-density lipoproteins for therapeutic delivery systems

Mutharasan, R. K., Foit, L., & Thaxton, C. S. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb01332a · Cited by 28

Lipid Nanoparticles for Broad‐Spectrum Nucleic Acid Delivery

Hejdankova, Z., Vaněk, V., Sedlák, F., Procházka, J., Diederichs, A., Kereı̈che, S., Novotná, B., Buděšı́nský, M., Birkuš, G., Šašková, K. G., et al. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202101391 · Cited by 27

Increased PIP3 activity blocks nanoparticle mRNA delivery

Paunovska, K., Sanchez, A. D. S., Foster, M. T., Loughrey, D., Blanchard, E. L., Islam, F. Z., Gan, Z., Mantalaris, A., Santangelo, P. J., & Dahlman, J. E. (2020) · Science Advances · doi:10.1126/sciadv.aba5672 · Cited by 26

Understanding structure activity relationships of Good HEPES lipids for lipid nanoparticle mRNA vaccine applications

Goldman, R., Murthy, N. T. V., Trent, N., Balakrishnan, A., Chivukula, S. V., Danz, H., Tibbitts, T. J., Dias, A., Vargas, J., Cooper, D. L., et al. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122243 · Cited by 26

Lipidoid Tail Structure Strongly Influences siRNA Delivery Activity

Knapp, C. M., Guo, P., & Whitehead, K. A. (2016) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-016-0436-9 · Cited by 26

The impact of, and expectations for, lipid nanoparticle technology: From cellular targeting to organelle targeting

Sato, Y., Nakamura, T., Yamada, Y., & Harashima, H. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.05.006 · Cited by 25

RNAi-Based Approaches for Pancreatic Cancer Therapy

Kim, M. J., Chang, H., Nam, G., Ko, Y., Kim, S. H., Roberts, T. M., & Ryu, J. H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101638 · Cited by 25

Pancreatic-targeted lipid nanoparticles based on organ capsule filtration

Lei, J., Yang, K., Cao, W., Qi, S., Du, X., Li, H., Wang, Y., Gan, J., Feng, Y., Li, Y., et al. (2026) · Nature · doi:10.1038/s41586-026-10158-7 · Cited by 28

New aspects of lipopeptide-incorporated nanoparticle synthesis and recent advancements in biomedical and environmental sciences: a review

Sharma, R. K., Dey, G., Banerjee, P., Maity, J. P., Lu, C.-M., Siddique, J. A., Wang, S.-C., Chatterjee, N., Das, K., & Chen, C. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb01564a · Cited by 24

Targeting Wnt-β-Catenin Signaling Pathway for Hepatocellular Carcinoma Nanomedicine

Bakrania, A. K., To, J. C., Zheng, G., & Bhat, M. (2023) · Gastro Hep Advances · doi:10.1016/j.gastha.2023.07.012 · Cited by 26

Effect of catecholamines on IL-2 production and NK cytotoxicity of rats in vitro.

Peng, Y.-P., Qiu, Y., Jiang, J., & Wang, J. (2004) · PubMed · Cited by 24

A review on selenium and gold nanoparticles combined photodynamic and photothermal prostate cancer tumors ablation

Charles, O. O., Musa, M., Otuyalo, A. I., Gbayisomore, T. J., Zainab, O. D., George, S. D., Popoola, P. O., Olofin, O. O., Umunnam, K. F., Nneji, P. O., et al. (2023) · Discover Nano · doi:10.1186/s11671-023-03936-z · Cited by 24

Lipid nanoparticles deliver mRNA to the blood–brain barrier

Kuzminich, Y., Shakked, A., Calkins, R., Rudden, S., Jones, C., Doan, J., Jang, B., Echeverri, E. S., Zenhausern, R., Lian, L., et al. (2024) · Nano Research · doi:10.1007/s12274-024-6827-7 · Cited by 25

Interaction design in mRNA delivery systems

Yu, M., Lin, L., Zhou, D., & Liu, S. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.11.038 · Cited by 25

Identification of a potent ionizable lipid for efficient macrophage transfection and systemic anti-interleukin-1β siRNA delivery against acute liver failure

Ding, F., Zhang, H., Li, Q., & Yang, C. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb00736j · Cited by 23

mRNA delivery technologies: Toward clinical translation

Gómez-Aguado, I., Rodríguez-Castejón, J., Beraza-Millor, M., Rodríguez‐Gascón, A., del Pozo‐Rodríguez, A., & Solinís, M. Á. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.04.010 · Cited by 23

Efficient mRNA delivery using lipid nanoparticles modified with fusogenic coiled-coil peptides

Zeng, Y., Shen, M., Pattipeiluhu, R., Zhou, X., Zhang, Y., Bakkum, T., Sharp, T. H., Boyle, A. L., & Kros, A. (2023) · Nanoscale · doi:10.1039/d3nr02175k · Cited by 24

Ligand Conjugated Multimeric siRNAs Enable Enhanced Uptake and Multiplexed Gene Silencing

Brown, J. M., Dahlman, J. E., Neuman, K. K., Prata, C. A. H., Krampert, M., Hadwiger, P., & Vornlocher, H. (2019) · Nucleic Acid Therapeutics · doi:10.1089/nat.2019.0782 · Cited by 23

APOE polymorphism in ATTR amyloidosis patients treated with lipid nanoparticle siRNA

Niemietz, C., Nadzemova, O., Zibert, A., & Schmidt, H. H.-J. (2020) · Amyloid · doi:10.1080/13506129.2019.1681392 · Cited by 22

Myeloid Cells As Orchestrators of the Tumor Microenvironment: Novel Targets for Nanoparticular Cancer Therapy

Tuettenberg, A., Steinbrink, K., & Schuppan, D. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0208 · Cited by 22

Lipopeptide nanoparticles (LPNs) for potent in vivo delivery of siRNA selectively to hepatocytes

(2014) · Science-Business eXchange · doi:10.1038/scibx.2014.239

In silico investigation of the siRNA binding with the cKK-E12 lipopeptide aiming at engineering advanced nanocarriers for gene therapies

Tsansizi, K. I. (2022) · DSpace - NTUA (National Technical University of Athens) · doi:10.26240/heal.ntua.22095

Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes

Hattori, Y., Machida, Y., Honda, M., Takeuchi, N., Yoshiike, Y., Ohno, H., & Onishi, H. (2016) · Journal of Liposome Research · doi:10.1080/08982104.2016.1205599 · Cited by 14

Cell penetrating peptide-mediated systemic siRNA delivery to the liver

Hayashi, Y., Yamauchi, J., Khalil, I. A., Kajimoto, K., Akita, H., & Harashima, H. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.07.038 · Cited by 66

Selective Cell Penetrating Peptide‐Functionalized Envelope‐Type Chimeric Lipopepsomes Boost Systemic RNAi Therapy for Lung Tumors

Qiu, M., Ouyang, J., Wei, Y., Zhang, J., Lan, Q., Deng, C., & Zhong, Z. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201900500 · Cited by 45